Nuveen AMT-Free Municipal Credit Income Fund of Beneficial Interest (NVG)
NYSE NYSE Primary NASDAQ Summary
NVG Chart
NervGen Pharma: I Think The Biggest Risks Are Now Behind It
NervGen Pharma remains a Buy, with reduced regulatory, financing, and execution risks following FDA alignment on the Phase 3 RESTORE trial. NGEN's recent $60M capital raise secures funding for its pivotal trial, shifting focus to NVG-291's ability to replicate efficacy in chronic tetraplegia. Objective biomechanical gait analysis showed statistically significant improvements, reinforcing the case for NVG-291's neural recovery over compensatory adaptation.
Nuveen AMT-Free Municipal Credit Income Fund of Beneficial Interest Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| CE Curtis Ellergodt Rothschild Investment LLC | 12,379 | $147,755.58 | $158,203.62 | $10,448.04 | 7.07% |
| PER Paul E. Rasmussen SIT INVESTMENT ASSOCIATES Inc. | 174,156 | $2.04M | $2.22M | $187,194.8 | 9.19% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 126,672 | $1.6M | $1.62M | $20,440.68 | 1.28% |
| WDW William Dudley Webb Jr. WORLD EQUITY GROUP Inc. | 23,250 | $285,211.62 | $297,018.75 | $11,807.13 | 4.14% |
 Texas Capital Bancshares Inc. Texas Capital Bancshares Inc. | 9,036 | $111,052 | $115,344.54 | $4,292.54 | 3.87% |
Nuveen AMT-Free Municipal Credit Income Fund of Beneficial Interest (NVG) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Nuveen AMT-Free Municipal Credit Income Fund of Beneficial Interest ever had a stock split?
Nuveen AMT-Free Municipal Credit Income Fund of Beneficial Interest Profile
| NYSE Exchange | US Country |
Overview
Nuveen AMT-Free Municipal Credit Income Fund of Beneficial Interest is a closed-end investment fund designed for investors seeking regular income that is exempt from federal income tax, including the federal alternative minimum tax that applies to individuals. Established in 1999 and managed from Chicago, the fund focuses primarily on tax-exempt municipal securities.
The fund's investment strategy highlights its commitment to identify bonds that are rated underrated, undervalued, or are part of underappreciated sectors within the municipal market. With the backing of Nuveen—a well-respected name in fixed-income management—the fund aims to provide consistent returns for investors looking for tax-advantaged income solutions while maintaining exposure to the U.S. municipal bond market.
Moreover, the fund permits up to 55% of its assets to be allocated to securities rated BBB or below, broadening its access to various credit sectors and potentially higher yield opportunities within the municipal bond universe. This investment approach positions the Nuveen AMT-Free Municipal Credit Income Fund as a significant vehicle for those looking to maximize tax efficiency in their fixed-income portfolios.
Products and Services
- Tax-Exempt Municipal Securities
The fund primarily invests in tax-exempt municipal securities, providing investors with the advantage of earning income that is exempt from federal income taxes.
- Closed-End Fund Structure
As a closed-end fund, it offers investors the ability to buy and sell shares on an exchange, providing liquidity and flexibility to investors who wish to enter or exit positions.
- Focused Investment Strategy
The fund concentrates on securities evaluated as underrated or undervalued, allowing for targeted investments that can capitalize on market inefficiencies.
- Flexible Credit Allocation
With the capability to invest up to 55% of its assets in securities rated BBB or below, the fund can tap into a wider range of credit sectors to potentially enhance returns.
- Tax Advantages
Nuveen AMT-Free Municipal Credit Income Fund is specifically tailored for investors looking for tax-advantaged income solutions, making it suitable for high-income individuals seeking to minimize their tax liabilities.
- Expert Management
Leveraging the expertise of Nuveen, the fund benefits from a well-established team specializing in fixed-income management, ensuring informed investment decisions based on market research and analysis.
